Genmab A/S
GMAB
$25.10
$0.301.21%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/5/2026
-
Insider Monkey
5/29/2026
-
Globe Newswire
5/23/2026
-
Tickeron - Stocks
5/21/2026
-
Globe Newswire
5/21/2026
-
Business Wire
5/14/2026
-
Seeking Alpha: Transcripts
5/13/2026
-
Insider Monkey
5/12/2026
-
Insider Monkey
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
Globe Newswire
5/10/2026
-
SeekingAlpha
5/9/2026
-
TipRanks Financial Blog
5/9/2026
-
The Cerbat Gem
5/8/2026
-
Globe Newswire
5/8/2026
-
MarketBeat
5/8/2026
-
The Cerbat Gem
5/8/2026
-
MarketBeat
5/7/2026
-
MarketBeat
5/7/2026
-
MarketBeat
5/4/2026
-
MarketBeat
5/4/2026
-
MarketBeat
5/2/2026
-
MarketBeat
5/2/2026
-
The Cerbat Gem
5/2/2026
-
Tickeron - Stocks
4/30/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, May 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
45 70 20 27 28
Address
Carl Jacobsens Vej 30
Copenhagen, 2500
Copenhagen, 2500
Country
Year Founded
Business Description
Sector
Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY...
more